TAC-TICS: Transposon-based insect control systems

被引:0
|
作者
Grigliatti, TA [1 ]
Pfeifer, TA [1 ]
Meister, GA [1 ]
机构
[1] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada
来源
ENHANCING BIOCONTROL AGENTS AND HANDLING RISKS | 2001年 / 339卷
关键词
D O I
暂无
中图分类号
S3 [农学(农艺学)];
学科分类号
0901 ;
摘要
We describe a system in which a specific population of a single pest insect type is targeted for management by making that population susceptible to control. In this paper we discuss the four key components of this genetic control system: transformation of the targeted insect; dissemination of the engineered construct throughout the targeted population; the inducible promoter to activate the expression of the fourth component; the incapacitating gene or genes. We describe the progress made in transformation of insects other than Drosophila. Using populations of model organisms, we show that transposon constructs can spread quite rapidly through a targeted population. We provide evidence that the multiplicative transposition process, which drives the spread of the engineered transposon construct, is not highly en-or prone and thus the use of TAC constructs in insect populations is feasible. The genes that might be used as relatively insect-specific incapacitating genes if over-expressed, mis-expressed or inactivated in specific insects or insect tissues include: genes that encode a variety of hormones and neuropeptides and their receptors; developmental selector genes, that is,. genes that control entry or exclusion of certain developmental pathways; genes that control components of signal cascades, which coordinate most of the physiological responses within and between tissues in an organism; cell cycle control genes; paralytic peptides; and many others. Finally we discuss a novel cell-based functional assay system which should allow investigators to test the function of inducible promoters, and some potential incapacitating genes, in a wide variety of insect systems prior to creating transgenic insect. Use of this in vivo test system should result in a significant saving of time in creating and testing specific TAC constructs.
引用
收藏
页码:201 / 216
页数:16
相关论文
共 50 条
  • [31] Identifying drivers for advanced prostate cancer by a transposon-based genetic screen
    Zou, Min
    Vasciaveo, Alessandro
    Califano, Andrea
    Abate-Shen, Cory
    CANCER RESEARCH, 2018, 78 (13)
  • [32] TnAraOut, A transposon-based approach to identify and characterize essential bacterial genes
    Judson, N
    Mekalanos, JJ
    NATURE BIOTECHNOLOGY, 2000, 18 (07) : 740 - 745
  • [33] A DNA transposon-based approach to functional screening in neural stem cells
    Albieri, Ilaria
    Onorati, Marco
    Calabrese, Giovanna
    Moiana, Alessia
    Biasci, Daniele
    Badaloni, Aurora
    Camnasio, Stefano
    Spiliotopoulos, Dimitrios
    Ivics, Zoltan
    Cattaneo, Elena
    Consalez, G. Giacomo
    JOURNAL OF BIOTECHNOLOGY, 2010, 150 (01) : 11 - 21
  • [34] A piggyBac transposon-based mutagenesis system for the fission yeast Schizosaccharomyces pombe
    Li, Jun
    Zhang, Jia-Min
    Li, Xin
    Suo, Fang
    Zhang, Mei-Jun
    Hou, Wenru
    Han, Jinghua
    Du, Li-Lin
    NUCLEIC ACIDS RESEARCH, 2011, 39 (06) : e40
  • [35] DNA transposon-based gene vehicles - scenes from an evolutionary drive
    Kristian Alsbjerg Skipper
    Peter Refsing Andersen
    Nynne Sharma
    Jacob Giehm Mikkelsen
    Journal of Biomedical Science, 20
  • [36] Transposon-Based Engineering of Clinical-Grade T Cells for Cancer Therapy
    Switzer, Kirsten
    Rabinovich, Brian
    Cooper, Laurence J. N.
    CURRENT DRUG THERAPY, 2012, 7 (01) : 36 - 41
  • [37] Transposon-based identification of a negative regulator for the antibiotic hyper-production in Streptomyces
    Luo, Shuai
    Chen, Xin-Ai
    Mao, Xu-Ming
    Li, Yong-Quan
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2018, 102 (15) : 6581 - 6592
  • [38] Target site selection of transposon-based vectors and strategies for targeted transgene insertion
    Ivics, Z.
    Ammar, I.
    Voigt, K.
    Gogol-Doering, A.
    Miskey, C.
    Chen, W.
    Izsvak, Z.
    Cathomen, T.
    HUMAN GENE THERAPY, 2011, 22 (10) : A4 - A4
  • [39] Transposon-Based CAR T Cells in Acute Leukemias: Where Are We Going?
    Magnani, Chiara F.
    Tettamanti, Sarah
    Alberti, Gaia
    Pisani, Ilaria
    Biondi, Andrea
    Serafini, Marta
    Gaipa, Giuseppe
    CELLS, 2020, 9 (06)
  • [40] Transposon-based identification of a negative regulator for the antibiotic hyper-production in Streptomyces
    Shuai Luo
    Xin-Ai Chen
    Xu-Ming Mao
    Yong-Quan Li
    Applied Microbiology and Biotechnology, 2018, 102 : 6581 - 6592